Dianthus Therapeutics Logo

Dianthus Therapeutics

🇺🇸
DNTH
US2528281080

Dianthus Therapeutics is a US-based biotechnology company specializing in the development of innovative complement inhibitors. Through targeted therapies, the company addresses severe autoimmune diseases and improves treatment options for patients.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
After-Hours
In 70 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Dianthus Therapeutics report its next quarterly earnings?

Dianthus Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Dianthus Therapeutics last report quarterly earnings?

Dianthus Therapeutics last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.90 USD.

How often has Dianthus Therapeutics beaten expectations?

Dianthus Therapeutics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).

How do I add the Dianthus Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.99
Actual:
Q2 2026
Missed
Estimate:-$0.85
Actual:-$0.90
Difference:-$0.05
Q1 2026
Beat
Estimate:-$1.07
Actual:-$0.85
Difference:+$0.22
Price reaction (1 day):+0.2 %
Price reaction (7 days):-4.5 %
Q4 2025
Missed
Estimate:-$1.01
Actual:-$1.43
Difference:-$0.42
Price reaction (1 day):+21.5 %
Price reaction (7 days):+19.6 %
Q2 2025
Missed
Estimate:-$0.90
Actual:-$0.97
Difference:-$0.07
Q1 2025
Missed
Estimate:-$0.87
Actual:-$0.88
Difference:-$0.01

Earnings statistics

Estimates vs. results

1/5
Quarters above estimates
20%
Beat rate
-5.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Dianthus Therapeutics
Ticker Symbol
DNTH
ISIN
US2528281080
Country
🇺🇸
USA
Sector